Equinor ASA (LON:0A7F)
25.35
-0.39 (-1.51%)
At close: Aug 1, 2025
Elevation Oncology Market Cap
Equinor ASA has a market cap or net worth of 47.14 billion as of August 1, 2025. Its market cap has decreased by -18.62% in one year.
Market Cap
47.14B
Enterprise Value
55.01B
Revenue
77.71B
Ranking
n/a
PE Ratio
7.86
Stock Price
$25.35
Market Cap Chart
Since June 18, 2001, Equinor ASA's market cap has increased from 11.55B to 47.14B, an increase of 308.11%. That is a compound annual growth rate of 6.00%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 47.14B | -7.35% |
Dec 30, 2024 | 50.88B | -30.95% |
Dec 29, 2023 | 73.67B | -21.55% |
Dec 30, 2022 | 93.91B | 46.64% |
Dec 30, 2021 | 64.04B | 57.84% |
Dec 30, 2020 | 40.58B | -19.15% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 172.19B |
HSBC Holdings | 159.21B |
Shell | 159.14B |
Unilever | 112.88B |
British American Tobacco p.l.c. | 90.29B |
Rolls-Royce Holdings | 89.59B |
Rio Tinto Group | 76.38B |
RELX PLC | 71.14B |